- Home
- SEAT vs QNCX Comparison
SEAT vs QNCX Comparison
Compare SEAT & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEAT
- QNCX
- Stock Information
- Founded
- SEAT 2001
- QNCX 2012
- Country
- SEAT United States
- QNCX United States
- Employees
- SEAT N/A
- QNCX N/A
- Industry
- SEAT Industrial Machinery/Components
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SEAT Industrials
- QNCX Health Care
- Exchange
- SEAT Nasdaq
- QNCX Nasdaq
- Market Cap
- SEAT 96.5M
- QNCX 88.6M
- IPO Year
- SEAT N/A
- QNCX 2019
- Fundamental
- Price
- SEAT $8.17
- QNCX $1.92
- Analyst Decision
- SEAT Buy
- QNCX Strong Buy
- Analyst Count
- SEAT 8
- QNCX 4
- Target Price
- SEAT $33.13
- QNCX $7.75
- AVG Volume (30 Days)
- SEAT 154.1K
- QNCX 361.1K
- Earning Date
- SEAT 11-06-2025
- QNCX 11-12-2025
- Dividend Yield
- SEAT N/A
- QNCX N/A
- EPS Growth
- SEAT N/A
- QNCX N/A
- EPS
- SEAT N/A
- QNCX N/A
- Revenue
- SEAT $643,775,000.00
- QNCX N/A
- Revenue This Year
- SEAT N/A
- QNCX N/A
- Revenue Next Year
- SEAT N/A
- QNCX N/A
- P/E Ratio
- SEAT N/A
- QNCX N/A
- Revenue Growth
- SEAT N/A
- QNCX N/A
- 52 Week Low
- SEAT $7.04
- QNCX $0.72
- 52 Week High
- SEAT $100.00
- QNCX $2.45
- Technical
- Relative Strength Index (RSI)
- SEAT 30.25
- QNCX 62.28
- Support Level
- SEAT $7.04
- QNCX $1.61
- Resistance Level
- SEAT $11.03
- QNCX $1.84
- Average True Range (ATR)
- SEAT 1.08
- QNCX 0.14
- MACD
- SEAT -0.27
- QNCX 0.03
- Stochastic Oscillator
- SEAT 20.12
- QNCX 91.18
About SEAT Vivid Seats Inc.
Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale. Marketplace segment, act as an intermediary between ticket buyers, sellers, and partners through which company earn revenue from processing ticket sales for live events and facilitating the booking of hotel rooms and packages on websites and mobile applications. Resale segment provides internal research and development support for Skybox and supplements ongoing efforts to deliver software and tools. Majority of revenue is from Marketplace segment.
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.